Microgynon 30

Ethinylestradiol, the active ingredient in Microgynon 30, is a combined oral contraceptive presented as a 30 µg ethinylestradiol / 150 µg levonorgestrel oral tablet for oral use. It prevents pregnancy in women of reproductive age and combines an estrogen with a progestogen to provide reliable contraception through multiple mechanisms.

GNH USA supplies Microgynon 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Microgynon 30, a combined oral contraceptive, is used to manage reproductive health conditions.

- Prevention of pregnancy: provides reliable contraception for women of childbearing age. - Menstrual cycle regulation: helps achieve predictable periods and reduces menstrual discomfort. - Acne management: may improve acne associated with hormonal fluctuations.

Microgynon 30 may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea - Headache - Breast tenderness - Spotting or irregular bleeding

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Stroke or myocardial infarction - Severe allergic reaction (anaphylaxis) - Liver tumor (hepatocellular adenoma)

Before prescribing Microgynon 30, clinicians should consider several safety precautions.

- Contraindicated in pregnancy: product must not be used by pregnant women. - Smoking over 15 cigarettes per day: increases cardiovascular risk. - History of thromboembolic disorders: assess risk before use. - Blood pressure monitoring: oral contraceptives may elevate blood pressure. - Drug interactions: review concomitant medications that may reduce efficacy. - Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Microgynon 30 can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): markedly reduce hormone levels. - Rifampicin: decreases contraceptive efficacy. - Protease inhibitors (e.g., ritonavir): may increase hormone concentrations and risk of side effects.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly lower effectiveness. - St John’s wort: can reduce contraceptive effect. - Diuretics: may enhance risk of hypertension.